Zusammenfassung
Schlafapnoe-Syndrome (SAS) beeinflussen die Funktion des Herz-Kreislauf-Systems. So können sie die Entstehung einer Herzinsuffizienz begünstigen. Umgekehrt kann eine chronische Herzinsuffizienz zum Auftreten eines Schlafapnoe-Syndroms führen. Diese wechselseitige Beziehung führt dazu, dass klinisch relevante Schlafapnoe-Syndrome bei Patienten mit einer symptomatischen Herzinsuffizienz besonders häufig sind. Dabei gibt es etwa ebenso viele zentrale (ZSAS) wie obstruktive (OSAS) Schlafapnoe-Syndrome. Beide Formen des Schlafapnoe-Syndroms führen zu rezidivierenden Apnoe-Phasen, die zu O2-Entsättigungen führen, welche einen Anstieg der Katecholaminspiegel im Blut zur Folge haben. Dies ist möglicherweise der entscheidende Mechanismus, der zu einer deutlich schlechteren Prognose von Patienten mit Herzinsuffizienz und SAS im Vergleich zu Patienten mit Herzinsuffizienz ohne SAS führt. Daher sollte ein regelmäßiges Screening aller Patienten mit Herzinsuffizienz auf ein Schlafapnoe-Syndrom erfolgen. Ob die Therapie eines SAS, insbesondere eines ZSAS, auch zu einer Verbesserung der Prognose von Patienten mit Herzinsuffizienz führt, wird derzeit in klinischen Studien überprüft (SERVE-HF, ADVENT-HF). Ein neuer Therapieansatz des zentralen Schlafapnoe-Syndroms ist die Stimulation des Nervus phrenicus, durch die Zwerchfellkontraktionen und damit Atemzüge getriggert werden können.
Abstract
Sleep apnea can influence cardiac function, by which the development of heart failure is facilitated. Vice versa, chronic heart failure increases the risk for sleep apnea. Consequently, in patients with symptomatic chronic heart failure, sleep apnea is a frequent comorbidity occuring in up to 75% of cases. More than half of those suffer from central sleep apnea, whereas in the general population, obstructive sleep apnea is far more frequent. Both, the obstructive and the central sleep apnea lead to oxygen desaturations during the night which are followed by increases in serum catecholamines. Possibly, this is the main mechanism why the prognosis of patients with symptomatic heart failure and sleep apnea is much worse than that of patients without sleep apnea. Therefore, a screening of all heart failure patients for sleep apnea is mandatory. Currently, large studies are underway which investigate whether the treatment of sleep apnea, esp. central sleep apnea, will beneficially influence the clinical course of heart failure (SERVE-HF, ADVENT-HF). A new therapeutic approach for central sleep apnea is the phrenic nerve stimulation.
Literatur
Zeller J, Hetzenecker A, Arzt M (2013) Sleep-disordered breathing in patients with chronic heart failure: epiphenomenon or bidirectional relationship. Pneumologie 67(3):150–156
Gottlieb DJ, Yenokyan G, Newman AB, O’Connor GT et al (2010) Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 122:352–360
Oldenburg O, Lamp B, Faber L et al (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9(3):251–257
Bitter T, Faber L, Hering D et al (2009) Sleep-disordered breathing in heart failure with normal ejection fraction. Eur J Heart Fail 11:602–608
Mayer G, Fietze I, Fischer J et al (2009) S3-Leitlinie „Nicht-erholsamer Schlaf“. Somnologie 13:4–160
Westhoff M (2013) Sleep related breathing disorders – classification, epidemiology, clinic, diagnostics and therapy. Klinikarzt 42(1):12–18
Lurie A (2011) Obstructive sleep apnea in adults: epidemiology, clinical presentation, and treatment options. Adv Cardiol 46:1–42
Dempsey JA, Veasey SC, Morgan BJ et al (2010) Pathophysiology of sleep apnea. Physiol Rev 90:47–112
Younes M (2008) Role of respiratory control mechanisms in the pathogenesis of obstructive sleep disorders. J Appl Physiol 105:1389–1405
Westhoff M, Arzt M, Litterst P (2012) Prevalence and treatment of central sleep apnoea emerging after initiation of continuous positive airway pressure in patients with obstructive sleep apnoea without evidence of heart failure. Sleep Breath 16:71–78
Berry RB, Budhiraja R, Gottlieb DJ et al (2012) Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 8(5):597–619
Büchner N, Sanner B (2013) Sleep and cardiac symptoms – interaction between sleep-related breathing disorders and cardiac diseases. Klinikarzt 42(1):20–26
Bradley TD, Floras JS (2003) Sleep apnea and heart failure: Part II: central sleep apnea. Circulation 107:1822–1826
Ip MS, Tse H, Lam B et al (2004) Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169:348–353
Minoguchi K, Yokoe T, Tazaki T et al (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625–630
Marin JM, Carrizo SJ, Vicente E et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053
Drager LF, Bortolotto LA, Lorenzi MC et al (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172:613–618
Westhoff M, Litterst P (2012) Obstruktive Schlafapnoe und oxidativer Stress. Pneumologie 66:610–615
Ross R (1999) Atherosclerosis – an inflammatory disease. N Engl J Med 340:115–126
Shimokawa H (1999) Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 31:23–37
Schulz R, Seeger W, Fegbeutel C et al (2005) Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 25:69–74
Suzuki M, Guilleminault C, Otsuka K et al (1996) Blood pressure „dipping“ and „non-dipping“ in obstructive sleep apnea syndrome patients. Sleep 19:382–387
Calhoun DA, Jones D, Textor S et al (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117:e510–e526
Shivalkar B, Heyning C van de, Kerremans M et al (2006) Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 47:1433–1439
Wang Q, Xi B, Liu M et al (2012) Short sleep duration is associated with hypertension risk among adults: a systematic review and meta-analysis. Hypertens Res 35:1012–1018
Verdecchia P, Schillaci G, Guerrieri M et al (1990) Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528–536
Mehra R, Benjamin EJ, Shahar E et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 173:910–916
Gami AS, Hodge DO, Herges RM et al (2007) Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49:565–571
Yumino D, Redolfi S, Ruttanaumpawan P et al (2010) Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 121:1598–1605
Redolfi S, Yumino D, Ruttanaumpawan P et al (2009) Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 179:241–246
Lorenzi-Filho G, Azevedo ER, Parker JD et al (2002) Relationship of carbon dioxide tension in arterial blood to pulmonary wedge pressure in heart failure. Eur Respir J 19:37–40
Solin P, Bergin P, Richardson M et al (1999) Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99:1574–1579
Arzt M, Harth M, Luchner A et al (2003) Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation 107:1998–2003
Tkacova R, Hall MJ, Liu PP et al (1997) Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am J Respir Crit Care Med 156:1549–1555
Naughton M, Benard D, Tam A et al (1993) Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 148:330–338
Solin P, Bergin P, Richardson M et al (1999) Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99:1574–1579
Garrigue S, Bordier P, Jais P et al (2002) Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 346:404–412
Sinha AM, Skobel EC, Breithardt OA et al (2004) Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 44:68–71
Mansfield DR, Solin P, Roebuck T et al (2003) The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest 124:1675–1681
Javaheri S, Abraham WT, Brown C et al (2004) Prevalence of obstructive sleep apnoea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J 25:260–266
McMurray JJV, Adamopoulos S, Anker SD et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14(8):803–869
Kushida CA, Littner MR, Hirshkowitz M et al; American Academy of Sleep Medicine (2006) Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 29:375–380
Tkacova R, Rankin F, Fitzgerald FS et al (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98:2269–2275
Usui K, Bradley TD, Spaak J et al (2005) Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45:2008–2011
Naughton MT, Benard DC, Liu PP et al (1995) Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152:473–479
Naughton MT, Rahman MA, Hara K et al (1995) Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 91:1725–1731
Kaneko Y, Floras JS, Usui K et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348:1233–1241
Malone S, Liu PP, Holloway R et al (1991) Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 338:1480–1484
Bradley TD, Logan AG, Kimoff RJ et al (2005) Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353:2025–2033
Arzt M, Floras JS, Logan AG et al (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115:3173–3180
Teschler H, Dohring J, Wang YM et al (2001) Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164:614–619
Allam JS, Olson EJ, Gay PC et al (2007) Efficacy of adaptive servoventilation in treatment of complex and central sleep apnea syndromes. Chest 132:1839–1846
Aurora RN, Chowdhuri S, Ramar K et al (2012) The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 35:17–40
Sharma BK, Bakker JP, McSharry DG et al (2012) Adaptive servo-ventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest 142:1211–1221
Randerath WJ, Nothofer G, Priegnitz C et al (2012) Long-term auto-servoventilation or constant positive pressure in heart failure and coexisting central with obstructive sleep apnea. Chest 142:440–447
Einhaltung der ethischen Richtlinien
Interessenkonflikt. J. Müller-Ehmsen und T. Plenge geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Plenge, T., Müller-Ehmsen, J. Schlafapnoe und Herzinsuffizienz. Herz 38, 604–609 (2013). https://doi.org/10.1007/s00059-013-3878-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-013-3878-z
Schlüsselwörter
- Zentrales Schlafapnoe-Syndrom (ZSAS)
- Obstruktives Schlafapnoe-Syndrom (OSAS)
- Cheyne-Stokes-Atmung
- Periodische Atmung
- Adaptive Servoventilation
- Nervus-phrenicus-Stimulation